Vanessa Mack (Dean) , a board-certified doctor, closely monitors your progress to help maximize results while ensuring your safety and well-being
The latest wave of the AMC consumer study shows that 7% of the population has used GLP-1 medications specifically for weight loss
When you lose muscle, metabolism slows down, making it even harder to continue losing weight
Currently approved weight management pharmacotherapy in the UK includes: Semaglutide (Wegovy) a GLP-1 receptor agonist approved by the MHRA for chronic weight management in adults, subject to NICE Technology Appraisal eligibility criteria [3] [5] Tirzepatide (Mounjaro) a dual GIP/GLP-1 receptor agonist approved by the MHRA for the treatment of type 2 diabetes
For management strategies, see our complete side effects guide
Combine protein supplementation with resistance training at least three times weekly to preserve muscle and maximize the metabolic benefits of your semaglutide treatment